Caroline Solas

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

Journal: The Journal of antimicrobial chemotherapy

Published: February 15, 2026

Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift Valley Fever Virus.

Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift Valley Fever Virus.

Journal: Antiviral research

Published: January 27, 2026

Comment on: Retrospective analysis of pharmacological therapeutic monitoring of caspofungin in patients undergoing continuous renal replacement therapy using polyacrylonitrile membranes.

Comment on: Retrospective analysis of pharmacological therapeutic monitoring of caspofungin in patients undergoing continuous renal replacement therapy using polyacrylonitrile membranes.

Journal: The Journal of antimicrobial chemotherapy

Published: January 19, 2026

Leakage of cabotegravir and rilpivirine in HIV patients receiving long-acting injectable antiretroviral therapy.

Leakage of cabotegravir and rilpivirine in HIV patients receiving long-acting injectable antiretroviral therapy.

Journal: The Journal of antimicrobial chemotherapy

Published: July 31, 2025

Probable disseminated cryptococcosis relapse in a patient with Hodgkin's lymphoma treated with induction therapy resumption and autologous stem cell transplant.

Probable disseminated cryptococcosis relapse in a patient with Hodgkin's lymphoma treated with induction therapy resumption and autologous stem cell transplant.

Journal: Journal de mycologie medicale

Published: July 08, 2025

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

Journal: CPT: pharmacometrics & systems pharmacology

Published: May 15, 2025

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.

Journal: Clinical and translational science

Published: May 12, 2025

Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.

Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.

Journal: Open forum infectious diseases

Published: March 12, 2025

Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 11, 2025

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients.

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients.

Journal: Annals of hematology

Published: December 09, 2024

A case of lenacapavir use for preventing mother-to-child HIV transmission.

A case of lenacapavir use for preventing mother-to-child HIV transmission.

Journal: The Journal of antimicrobial chemotherapy

Published: September 30, 2024

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.

Journal: Heliyon

Published: January 09, 2024

Showing 1-12 of 102

Last Updated: 09/26/2026